NCT06491264

Brief Summary

With an aging population worldwide, it is critical to develop effective interventions promoting healthy cognitive aging. Transcranial electrical stimulation (tES) is a promising but not fully realized noninvasive brain stimulation approach that could improve memory. This study investigates the behavioral and electrocortical effects of personalized tES in aging to determine whether whether optimal dosing, electrode placements, and waveforms elicit stronger responses.

Trial Health

45
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Timeline
12mo left

Started Dec 2026

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 17, 2024

Completed
3 months until next milestone

First Posted

Study publicly available on registry

July 9, 2024

Completed
2.5 years until next milestone

Study Start

First participant enrolled

December 31, 2026

Expected
Same day until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2026

1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2027

Last Updated

February 25, 2026

Status Verified

February 1, 2026

Enrollment Period

Same day

First QC Date

April 17, 2024

Last Update Submit

February 23, 2026

Conditions

Outcome Measures

Primary Outcomes (2)

  • Electrocortical EEG changes pre- to post-tES

    Observe effects of each tES condition within each of the 5 sessions, as measured by TMS-EEG

    1 year

  • N-back working memory changes pre- to post-tES

    Observe effects of each tES condition within each of the 5 sessions on the N-back memory task

    1 year

Secondary Outcomes (1)

  • Rate of side effects from tES

    1 year

Study Arms (5)

Personalized tES stimulation #1

EXPERIMENTAL

tES will be applied with personalized parameters in condition #1 for approximately 20 minutes.

Device: Transcranial electrical stimulation

Personalized tES stimulation #2

EXPERIMENTAL

tES will be applied with personalized parameters in condition #2 for approximately 20 minutes.

Device: Transcranial electrical stimulation

Personalized tES stimulation #3

EXPERIMENTAL

tES will be applied with personalized parameters in condition #3 for approximately 20 minutes.

Device: Transcranial electrical stimulation

Standard tES

EXPERIMENTAL

Standard tES will be applied in condition #4 for approximately 20 minutes.

Device: Transcranial electrical stimulation

Sham tES stimulation

SHAM COMPARATOR

A sham (placebo) comparison condition will be applied in condition #5 for approximately 20 minutes.

Device: Transcranial electrical stimulation

Interventions

We will administer active transcranial electrical stimulation in one of the 4 active stimulation conditions and 1 sham stimulation condition.

Personalized tES stimulation #1Personalized tES stimulation #2Personalized tES stimulation #3Sham tES stimulationStandard tES

Eligibility Criteria

Age50 Years - 85 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • y.o.
  • Endorse good health with no history of mental or physical illness
  • Willingness to adhere to the study schedule and assessments
  • Able to read consent document and provide informed consent.
  • English is a first or primary fluent language.

You may not qualify if:

  • Any current psychiatric diagnosis or current Clinical Global Impression ratings of psychiatric illness \> 1
  • Neurodevelopmental disorders, history of Central Nervous System (CNS) disease, concussion, overnight hospitalization, or other neurologic sequela, tumors, seizures, meningitis, encephalitis, or abnormal CT or MRI of the brain
  • Any psychotropic medication is taken within 5 half-lives of procedure time
  • Any head trauma resulting in loss of consciousness
  • Visual impairment (except the use of glasses)
  • Inability to complete cognitive testing
  • Active participation or plan for enrollment in another evidence-based clinical trial affecting the psychosocial function
  • Repeated abuse or dependence upon drugs (excluding nicotine and caffeine) or taking medications including stimulants, modafinil, thyroid medication, or steroids
  • Implanted devices/ferrous metal of any kind
  • History of seizure or epilepsy, currently taking medications that lower seizure thresholds
  • Claustrophobia or other conditions that would prevent the MRI assessment.
  • Pregnancy (or suspected/possible pregnancy or plan to become pregnant in the short term).
  • Urine Pregnancy Test: If the subject is a woman of childbearing potential and /or a man capable of fathering a child before, during, and/or after participation precautions should be taken. Examples of acceptable methods of birth control for participants involved in the study include birth control pills, patches, Intrauterine Devices (IUD), condoms, sponges, diaphragm with spermicide, or avoiding sexual activity that could cause the subject to become pregnant.
  • Inability to adhere to the treatment schedule.
  • Inability to fit the wearable device to the user's head.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Interventions

Transcranial Direct Current Stimulation

Intervention Hierarchy (Ancestors)

Electric Stimulation TherapyTherapeuticsConvulsive TherapyPsychiatric Somatic TherapiesBehavioral Disciplines and ActivitiesElectroshockPsychological Techniques

Study Officials

  • Kevin Caulfield, PhD

    Medical University of South Carolina

    PRINCIPAL INVESTIGATOR
0

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Masking Details
Double-blind, sham-controlled
Purpose
BASIC SCIENCE
Intervention Model
CROSSOVER
Model Details: In this within-subjects design, participants will each receive 5 sessions of tES in a counterbalanced order. tES will be applied using different stimulation intensities that are personalized to each person using MRI scans. tES will also have different 4 different waveforms (theta, gamma, theta-gamma ranges or none).
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

April 17, 2024

First Posted

July 9, 2024

Study Start (Estimated)

December 31, 2026

Primary Completion (Estimated)

December 31, 2026

Study Completion (Estimated)

December 31, 2027

Last Updated

February 25, 2026

Record last verified: 2026-02